de
  • Deutsch - de
  • English - en
  • Über uns
      Über uns
        Maßnahmen
          Mitglieder
            Cluster Management
              PhD und Postdoc-Vertreter
                Wissenschaftlicher Beirat
                  Internationale Kooperationspartner
                    Timeline
                      Pressekit
                        Kontakt
                      • Aktuelles
                          News
                            Veranstaltungen
                              Presseecho
                                Stellenausschreibungen
                              • Forschung
                                  Publikationen
                                    Unser Forschungsschwerpunkt
                                      Technology Hubs
                                        "Research Spotlight"
                                          Datenmanagement & -austausch
                                            Sustainability Initiative
                                              Verhaltenskodex
                                            • Wissenschaft & Gesellschaft
                                                Für Schulen und Schüler
                                                  Öffentliche Veranstaltungen
                                                    Podcasts
                                                      Videos
                                                    • Support für Diversity & Equity
                                                        Newcomer Center
                                                          Gender Equality Program
                                                            Early Career Investigator Programm
                                                          1. Home
                                                          2. Aktuelles
                                                          3. News
                                                          4. A new therapeutic approach for atherosclerosis: the role of CXCR4 & microRNA
                                                          News | 04.12.2023 | Research Spotlight

                                                          A new therapeutic approach for atherosclerosis: the role of CXCR4 & microRNA

                                                          The chemokine receptor CXCR4 in vascular smooth muscle cells and endothelial cells has a protective function for vessels. Researchers found a microRNA molecule that can regulate CXCR4, offering a promising starting point for new therapies. 
                                                           Research Spotlight: Photo of the researcher and a quote about the impact of the research

                                                          This is a summary of Ismail Çimen, Lucia Natarelli, Zahra Abedi Kichi, James M. Henderson, Floriana M.Farina, Eva Briem, Maria Aslani, (…), Donato Santovito, Christian Weber: Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice (2023). https://doi.org/10.1126/scitranslmed.adf3357, which appeared in Science Translational Medicine.


                                                          The challenge

                                                          Atherosclerosis, a thickening or hardening of the arteries by plaques, is considered a frequent cause of cardiovascular diseases and strokes. Some time ago, we discovered that the transmembrane protein CXCR4 plays a significant role in its development by transmitting signals to the cell interior. We found that if CXCR4 is silenced in the arterial endothelial or smooth muscle cells, the atherosclerotic lesions worsen. Whereas concerning leukocytes, we found the opposite effect: CXCR4 presence leads to more inflammation. Therefore, to counteract atherosclerosis, we wanted to boost the expression of CXCR4 on the vascular wall only, not on the leukocytes, without influencing any other biological process. We, therefore, searched for microRNA molecules that are limited to vascular cells and are involved in the regulation of CXCR4.


                                                          Our approach

                                                          Using databases, molecular biological screening in cell cultures, and mouse models we found a good candidate: miR-206. This microRNA occurs only in endothelial cells and in vascular smooth muscle cells where it downregulates the expression of CXCR4 by binding to the transcripts of the CXCR4 gene and preventing their conversion into the protein. For therapeutic application, the effect of miR-206 needs to be suppressed. Therefore, we developed a so-called target-site blocker (TSB): a molecule that specifically interrupts interactions between miR-206 and the CXCR4 transcripts and thus only boosts its expression in the respective cells.


                                                          Our findings

                                                          We demonstrated the effectiveness of the target-site blocker: it increased CXCR4 in vascular cells in cell cultures. Moreover, it was able to prevent atherosclerosis in the mouse model.


                                                          The implications

                                                          We showed that our approach is a potential therapeutic approach that could be used to treat atherosclerosis and other vascular diseases. Eliminating microRNA-mediated gene suppression represents an attractive, feasible, and cost-effective method for fine-tuning gene expression at the cell-specific level.


                                                          Creating SyNergies

                                                          This research was led by Christian Weber from SyNergy together with Donato Santovito from LMU. They plan to evaluate their results in preclinical studies with larger animal models within the framework of the German Cardiovascular Research Centre (DZHK) and the Cluster for Nucleic Acid Therapeutics Munich (CNATM), and last but not least within the DFG Excellence Cluster SyNergy, where therapeutic applicability to stroke models and neuroprotective effects will be explored.

                                                          Teilnehmende Universitäten
                                                           LMU logo in white
                                                           TUM logo in white
                                                          Partnerinstitute
                                                           Logo DZNE in white
                                                          Helmholtz Munich logo in white 
                                                           Logo Max Planck Gesellschaft 

                                                          SyNergy wird von der Deutschen Forschungsgemeinschaft im Rahmen der deutschen Exzellenzstrategie gefördert (EXC 2145 SyNergy - ID 390857198). Die Exzellenzstrategie fördert herausragende Forschung an deutschen Universitäten. 

                                                          Kontakt

                                                          Munich Cluster for Systems Neurology (SyNergy)

                                                          Feodor-Lynen-Str. 17
                                                          81377 Munich
                                                          +49 (0)89 4400-46497
                                                          yüubgybcјWuipxјGvfulyzsmi
                                                          Redakteurs Login
                                                          Impressum | Datenschutz
                                                          de
                                                          • Deutsch - de
                                                          • English - en

                                                          SyNergy - Mu...

                                                          • Über uns
                                                            • Über uns
                                                            • Maßnahmen
                                                            • Mitglieder
                                                            • Cluster Management
                                                            • PhD und Postdoc-Vertreter
                                                            • Wissenschaftlicher Beirat
                                                            • Internationale Kooperationspartner
                                                            • Timeline
                                                            • Pressekit
                                                            • Kontakt
                                                          • Aktuelles
                                                            • News
                                                            • Veranstaltungen
                                                            • Presseecho
                                                            • Stellenausschreibungen
                                                          • Forschung
                                                            • Publikationen
                                                            • Unser Forschungsschwerpunkt
                                                            • Technology Hubs
                                                            • "Research Spotlight"
                                                            • Datenmanagement & -austausch
                                                            • Sustainability Initiative
                                                            • Verhaltenskodex
                                                          • Wissenschaft & Gesellschaft
                                                            • Für Schulen und Schüler
                                                            • Öffentliche Veranstaltungen
                                                            • Podcasts
                                                            • Videos
                                                          • Support für Diversity & Equity
                                                            • Newcomer Center
                                                            • Gender Equality Program
                                                            • Early Career Investigator Programm